Studies elucidating the role of immune evasion by tumor cells have led to several revelations, including the generation of combined positive score (CPS) based on PD‐L1 expression in tumor cells for the assessment of treatment response in HNSCC. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.